Jairo Luis Coelho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jairo Luis Coelho has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- José Tadeu Campos de Avelar
Mater Dei Hospital
2 shared publications - Renata Capanema Saliba Franco
Mater Dei Hospital
2 shared publications - Anna Dias Salvador
Mater Dei Hospital
1 shared publication - Bernardo Bacelar de Faria
Diagnostic Medicine Laboratory-Scapulatempo, Campo Grande 79002-17, Brazil
1 shared publication - Elizabeth Asuncion Sanchez de Ayub
Mater Dei Rede de Saúde
1 shared publication - Gabriel Oliveira Bernardes Gil
Radiation Oncology; Rede Mater Dei de Saúde; Belo Horizonte Brazil
1 shared publication
Latest Publications
- Open Access
Impact of artificial intelligence on breast care pathways and future perspectives
Artificial intelligence (AI) is a sophisticated technology already established in medicine. In mastology, there is robust evidence of the ability of AI software to optimize screening, reduce interval cancer rates, and decrease patient recall rates. In addition, AI provides parameters for predicting surgical complications and oncological therapeutic outcomes. Considering the rise of AI, this article aimed to conduct an integrative review, highlighting its main tools developed in mastology. A search was performed on the United States National Library of Medicine (PubMed) platform, using descriptors associated with AI and breast cancer. Retrospective studies, systematic reviews, and prospective clinical studies published in English in the last ten years were included. The results were organized by thematic areas and summarized in a table and the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) flowchart. Data analysis showed a concentration of information in the area of imaging — with advances in radiomics — and a still incipient, albeit promising, development in areas such as genetics and surgery. The article highlights the need for discussion on the ethical issues surrounding the implementation of AI. The reliability of data collection and manipulation must be guaranteed, and data automation should not imply automation of conduct, since medical responsibility in patient care is perennial.
Open AccessImpact of artificial intelligence on breast care pathways and future perspectives
Artificial intelligence (AI) is a sophisticated technology already established in medicine. In mastology, there is robust evidence of the ability of AI software to optimize screening, reduce interval cancer rates, and decrease patient recall rates. In addition, AI provides parameters for predicting surgical complications and oncological therapeutic outcomes. Considering the rise of AI, this article aimed to conduct an integrative review, highlighting its main tools developed in mastology. A search was performed on the United States National Library of Medicine (PubMed) platform, using descriptors associated with AI and breast cancer. Retrospective studies, systematic reviews, and prospective clinical studies published in English in the last ten years were included. The results were organized by thematic areas and summarized in a table and the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) flowchart. Data analysis showed a concentration of information in the area of imaging — with advances in radiomics — and a still incipient, albeit promising, development in areas such as genetics and surgery. The article highlights the need for discussion on the ethical issues surrounding the implementation of AI. The reliability of data collection and manipulation must be guaranteed, and data automation should not imply automation of conduct, since medical responsibility in patient care is perennial.
- Open Access
Vacuum-assisted biopsy and excision of breast lesions: review and current indications
Vacuum-assisted biopsy is an advance in breast diagnostics because it is a less invasive and more practical approach than conventional surgery, capable of diagnosing and treating certain lesions. Despite the still limited availability of the method, related to its cost and the number of professionals qualified to perform it, the potential of vacuum-assisted biopsy and excision in the practice of mastologists is unquestionable. The attending physician is expected to understand the methods, as well as the indications pertinent to them. Recognizing the impossibility of exhausting the subject, the objective of this study is to conduct a narrative review, summarizing the indications for vacuum-assisted breast biopsy and excision currently, according to the available scientific evidence.
Open AccessVacuum-assisted biopsy and excision of breast lesions: review and current indications
Vacuum-assisted biopsy is an advance in breast diagnostics because it is a less invasive and more practical approach than conventional surgery, capable of diagnosing and treating certain lesions. Despite the still limited availability of the method, related to its cost and the number of professionals qualified to perform it, the potential of vacuum-assisted biopsy and excision in the practice of mastologists is unquestionable. The attending physician is expected to understand the methods, as well as the indications pertinent to them. Recognizing the impossibility of exhausting the subject, the objective of this study is to conduct a narrative review, summarizing the indications for vacuum-assisted breast biopsy and excision currently, according to the available scientific evidence.